CRIP1 and lymphangioma: VEGFC binding to its receptor VEGFR3 can activate VEGFC/VEGFR3 signaling and enhance formation of new lymphatic vessels, leading to LM development.[32, 33, 34] Here, we first reported that VEGFC expression could be markedly increased by CRIP1.